138 related articles for article (PubMed ID: 29256223)
1. [CXC chemokine receptor 4 regulates breast cancer cell cycle through S phase kinase associated protein 2].
Wang H; Chen T; Wang Y; Li Y; Zhang L; Ding Y; Chen S; Wang W; Yang Q; Chen C
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 46(4):357-363. PubMed ID: 29256223
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways.
Shen X; Artinyan A; Jackson D; Thomas RM; Lowy AM; Kim J
Pancreas; 2010 Jan; 39(1):81-7. PubMed ID: 19820417
[TBL] [Abstract][Full Text] [Related]
3. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion.
Leelawat K; Leelawat S; Narong S; Hongeng S
World J Gastroenterol; 2007 Mar; 13(10):1561-8. PubMed ID: 17461449
[TBL] [Abstract][Full Text] [Related]
4. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
Jang K; Kim M; Seo HS; Shin I
Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
[TBL] [Abstract][Full Text] [Related]
5. The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation.
Liu X; Wang H; Ma J; Xu J; Sheng C; Yang S; Sun L; Ni Q
Med Oncol; 2013 Dec; 30(4):735. PubMed ID: 24277465
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
7. [Cross-talk between PI3K/Akt and MEK/ERK pathways regulates human hepatocellular carcinoma cell cycle progression under endoplasmic reticulum stress].
Yan DM; Dai RY; Duan CY; Chen SK; Liu YP; Chen CN; Li H
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):909-14. PubMed ID: 21205476
[TBL] [Abstract][Full Text] [Related]
8. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines.
Wang L; Wu J; Lu J; Ma R; Sun D; Tang J
Mol Med Rep; 2015 Feb; 11(2):931-9. PubMed ID: 25355053
[TBL] [Abstract][Full Text] [Related]
10. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
Reichert M; Saur D; Hamacher R; Schmid RM; Schneider G
Cancer Res; 2007 May; 67(9):4149-56. PubMed ID: 17483325
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
13. Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.
Ramakrishnan V; Kimlinger T; Haug J; Painuly U; Wellik L; Halling T; Rajkumar SV; Kumar S
PLoS One; 2012; 7(11):e50005. PubMed ID: 23185517
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
16. AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells.
Zhou Z; Deng H; Yan W; Luo M; Tu W; Xia Y; He J; Han P; Fu Y; Tian D
PLoS One; 2014; 9(6):e100372. PubMed ID: 24941119
[TBL] [Abstract][Full Text] [Related]
17. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines.
Li H; Schmid-Bindert G; Wang D; Zhao Y; Yang X; Su B; Zhou C
Adv Med Sci; 2011; 56(2):275-84. PubMed ID: 22037177
[TBL] [Abstract][Full Text] [Related]
18. The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
Park S; Bazer FW; Lim W; Song G
J Cell Biochem; 2018 Sep; 119(9):7377-7387. PubMed ID: 29761845
[TBL] [Abstract][Full Text] [Related]
19. Baicalein and Ly294002 induces liver cancer cells apoptosis via regulating phosphatidyl inositol 3-kinase/Akt signaling pathway.
He K; Yu X; Wang X; Tang L; Cao Y; Xia J; Cheng J
J Cancer Res Ther; 2018 Jun; 14(Supplement):S519-S525. PubMed ID: 29970718
[TBL] [Abstract][Full Text] [Related]
20. Progesterone modulates endothelial progenitor cell (EPC) viability through the CXCL12/CXCR4/PI3K/Akt signalling pathway.
Yu P; Zhang Z; Li S; Wen X; Quan W; Tian Q; Chen J; Zhang J; Jiang R
Cell Prolif; 2016 Feb; 49(1):48-57. PubMed ID: 26818151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
